Clinical and economic effectiveness of using immunotherapeutic drugs in patients with urothelial carcinoma in the healthcare system of the Russian Federation | Krysanov | Cancer Urology

Cancer Urology
Onkourologiâ

ISSN 1726-9776 (Print)
ISSN 1996-1812 (Online)

eng | рус

Preview

Cancer Urology

Advanced search

Archives

Download this PDF file

For citations:

Krysanov I.S., Makarova E.V., Kurkin D.V., Ermakova V.Yu. Clinical and economic effectiveness of using immunotherapeutic drugs in patients with urothelial carcinoma in the healthcare system of the Russian Federation. Cancer Urology. 2023;19(4):104-113. (In Russ.) https://doi.org/10.17650/1726-9776-2023-19-4-104-113

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 License.

ISSN 1726-9776 (Print)
ISSN 1996-1812 (Online)

* not an advertisement

Indexing Databases

* not an advertisement

Popular articles

Editor-in-Chief

Boris Ya. Alekseev

About the Authors

I. S. Krysanov
Russian Biotechnological University; Russian University of Medicine, Ministry of Health of Russia
Russian Federation

Ivan S. Krysanov

11 Volokolamskoe Shosse, Moscow 125080,

20/1 Delegatskaya St., Moscow 127473

E. V. Makarova
Russian University of Medicine, Ministry of Health of Russia
Russian Federation

20/1 Delegatskaya St., Moscow 127473

D. V. Kurkin
Russian University of Medicine, Ministry of Health of Russia
Russian Federation

20/1 Delegatskaya St., Moscow 127473

V. Yu. Ermakova
I.M. Sechenov First Moscow State Medical University, Ministry of Health of Russia (Sechenov University)
Russian Federation

Build. 4, 2 Bol’shaya Pirogovskaya St., Moscow 119435

Notifications

Article Tools

Finding References

Email this article (Login required)

Email the author (Login required)

X